Search - tctmd.com

Displaying 1 - 20 of 20

Sort: Relevancy | Date

News Industry News

Fondazione Ricerca e Innovazione Cardiovascolare Completes Enrollment in TRANSFORM II RCT, A landmark study comparing MagicTouch SCB vs DES in Native Coronary Vessels

June 12, 2025

News Industry News

Concept Medical receives US FDA approval for MagicTouch AVF indication, their fifth US clinical study approval for the MagicTouch portfolio

April 03, 2024

News Industry News

TRANSFORM 1 Enrollment Completed: A Crucial RCT ready to redefine the DCB Angioplasty Mechanism

September 13, 2022

News Industry News

SMT Announces CE* Mark for the Most Deliverable Stent Supraflex Cruz

July 11, 2019

News Industry News

Latest generation DES: ANGIOLITE trial 24-month outcomes revealed at EuroPCR 2019 the non-inferiority of angiolite vs the gold standard EES

May 23, 2019

News Industry News

FDA Approves First Balloon Expandable Stent Graft for Use in the Iliac Artery

January 30, 2017

News Industry News

Trial Results Suggest That Drug-Eluting Stents Are Acceptable Alternative To Open Heart Surgery For Select Patients With Left Main Coronary Artery Disease

October 31, 2016

News Industry News

Veryan Medical announces that the first patient has been enrolled into the Company sponsored MIMICS-3D Registry by Michael Lichtenberg MD of Arnsberg, Germany

September 15, 2016

News Industry News

SurModics Announces First Patient Enrolled in IDE Study of SurVeil™ Drug-Coated Balloon

April 06, 2016

News Industry News

Micell Technologies Highlights Data From Published Propensity Analysis of MiStent SES® and Market Standard Xience V® Coronary Stent

February 24, 2016

News Industry News

Boston Scientific Receives CE Mark For Eluvia™ Drug-Eluting Vascular Stent and Announces Initiation of New Clinical Trial

February 21, 2016

News Industry News

First-In-Man Study Examines Angiographic And Clinical Outcomes Of Newest Bioresorbable Magnesium Stent

October 12, 2015

News Industry News

SurModics Receives FDA IDE Approval for Early Feasibility Study of the SurVeil™ Drug-Coated Balloon

October 06, 2015

News Industry News

Minneapolis Heart Institute® Physician Serves as National PI in Research Trial Aiming to Improve Outcomes for Those with Peripheral Arterial Disease

July 21, 2015

News Industry News

First Subject Enrolled in Veryan Medical's MIMICS-2 Study

July 01, 2015

News Industry News

EuroPCR Late-Breaking Clinical Trials: MiStent SES® Shows Clinical Superiority over Market-Leader Xience V in Propensity Analysis at One and Three Years Post-Treatment

May 19, 2015

News Industry News

Antiplatelet Drug Ticagrelor More Effective Than Clopidogrel for Ad Hoc PCI Patients

May 07, 2015

News Industry News

NeuroSigma's Thin Film Nitinol Flow Diverting Stent Results Presented at the American Society of Neuroradiology Meeting

May 04, 2015

News Industry News

Boston Scientific Begins Clinical Trial Enrollment for OMEGA™ Platinum Chromium Stent System

October 05, 2011

News Industry News

NSVascular, Inc., a NeuroSigma Subsidiary, Signs an Exclusive License Covering UCLA's Thin-Film Nitinol (TFN) Stent Technology for Endovascular Applications

July 18, 2011

Advertisement

Fondazione Ricerca e Innovazione Cardiovascolare Completes Enrollment in TRANSFORM II RCT, A landmark study comparing MagicTouch SCB vs DES in Native Coronary Vessels

Concept Medical receives US FDA approval for MagicTouch AVF indication, their fifth US clinical study approval for the MagicTouch portfolio

TRANSFORM 1 Enrollment Completed: A Crucial RCT ready to redefine the DCB Angioplasty Mechanism

SMT Announces CE* Mark for the Most Deliverable Stent Supraflex Cruz

Latest generation DES: ANGIOLITE trial 24-month outcomes revealed at EuroPCR 2019 the non-inferiority of angiolite vs the gold standard EES

FDA Approves First Balloon Expandable Stent Graft for Use in the Iliac Artery

Trial Results Suggest That Drug-Eluting Stents Are Acceptable Alternative To Open Heart Surgery For Select Patients With Left Main Coronary Artery Disease

Veryan Medical announces that the first patient has been enrolled into the Company sponsored MIMICS-3D Registry by Michael Lichtenberg MD of Arnsberg, Germany

SurModics Announces First Patient Enrolled in IDE Study of SurVeil™ Drug-Coated Balloon

Micell Technologies Highlights Data From Published Propensity Analysis of MiStent SES® and Market Standard Xience V® Coronary Stent

Boston Scientific Receives CE Mark For Eluvia™ Drug-Eluting Vascular Stent and Announces Initiation of New Clinical Trial

First-In-Man Study Examines Angiographic And Clinical Outcomes Of Newest Bioresorbable Magnesium Stent

SurModics Receives FDA IDE Approval for Early Feasibility Study of the SurVeil™ Drug-Coated Balloon

Minneapolis Heart Institute® Physician Serves as National PI in Research Trial Aiming to Improve Outcomes for Those with Peripheral Arterial Disease

First Subject Enrolled in Veryan Medical's MIMICS-2 Study

EuroPCR Late-Breaking Clinical Trials: MiStent SES® Shows Clinical Superiority over Market-Leader Xience V in Propensity Analysis at One and Three Years Post-Treatment

Antiplatelet Drug Ticagrelor More Effective Than Clopidogrel for Ad Hoc PCI Patients

NeuroSigma's Thin Film Nitinol Flow Diverting Stent Results Presented at the American Society of Neuroradiology Meeting

Boston Scientific Begins Clinical Trial Enrollment for OMEGA™ Platinum Chromium Stent System

NSVascular, Inc., a NeuroSigma Subsidiary, Signs an Exclusive License Covering UCLA's Thin-Film Nitinol (TFN) Stent Technology for Endovascular Applications

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content